MX383470B - Cuantificación de porción de glicano en glicoproteínas recombinantes. - Google Patents

Cuantificación de porción de glicano en glicoproteínas recombinantes.

Info

Publication number
MX383470B
MX383470B MX2017006463A MX2017006463A MX383470B MX 383470 B MX383470 B MX 383470B MX 2017006463 A MX2017006463 A MX 2017006463A MX 2017006463 A MX2017006463 A MX 2017006463A MX 383470 B MX383470 B MX 383470B
Authority
MX
Mexico
Prior art keywords
quantification
recombinant glycoproteins
glycan portion
glycan
recombinant
Prior art date
Application number
MX2017006463A
Other languages
English (en)
Other versions
MX2017006463A (es
Inventor
Letha Chemmalil
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of MX2017006463A publication Critical patent/MX2017006463A/es
Publication of MX383470B publication Critical patent/MX383470B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/74—Optical detectors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8831—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)

Abstract

La presente invención se refiere a un método para determinar la porción de glicano en una glicoproteína recombinante usando detección de dispersión de luz de formación de núcleos por condensación.
MX2017006463A 2014-11-19 2015-11-19 Cuantificación de porción de glicano en glicoproteínas recombinantes. MX383470B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462082014P 2014-11-19 2014-11-19
PCT/US2015/061684 WO2016081770A1 (en) 2014-11-19 2015-11-19 Quantitation of glycan moiety in recombinant glycoproteins

Publications (2)

Publication Number Publication Date
MX2017006463A MX2017006463A (es) 2018-04-20
MX383470B true MX383470B (es) 2025-03-14

Family

ID=54754830

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017006463A MX383470B (es) 2014-11-19 2015-11-19 Cuantificación de porción de glicano en glicoproteínas recombinantes.

Country Status (9)

Country Link
US (1) US11275090B2 (es)
EP (2) EP3221465B1 (es)
JP (2) JP2018502287A (es)
AU (1) AU2015349809B2 (es)
CA (1) CA2968372A1 (es)
ES (2) ES2727380T3 (es)
HK (1) HK1244037B (es)
MX (1) MX383470B (es)
WO (1) WO2016081770A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107045019B (zh) * 2016-09-30 2019-08-16 中国医学科学院输血研究所 一种IVIG中IgG Fab片段和Fc片段唾液酸含量的测定方法
CN106908528A (zh) * 2017-02-14 2017-06-30 信达生物制药(苏州)有限公司 蛋白类药物中唾液酸的检测方法
KR101923662B1 (ko) * 2017-12-28 2018-11-30 (주)글라이칸 비인간형 당사슬 NeuGc를 포함하는 시알산 고감도 분석방법 및 이를 이용한 분석용 킷트
JP7343890B2 (ja) * 2019-04-26 2023-09-13 国立大学法人東海国立大学機構 シアリダーゼ活性を有する酵素剤及びその利用
EP3983781B1 (en) * 2019-06-14 2025-05-07 Agilent Technologies, Inc. Methods and kits to improve the fluorescent signal of dmb-labeled sialic acids
EP4062176B1 (en) * 2019-11-21 2024-05-22 Bristol-Myers Squibb Company Label-free n-glycan quantification methods
WO2024259275A1 (en) * 2023-06-14 2024-12-19 Bristol-Myers Squibb Company Near real time sialic acid quantitation of glycoproteins

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
AU588819B2 (en) 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
WO1990005183A1 (en) 1988-10-31 1990-05-17 Immunex Corporation Interleukin-4 receptors
US5395760A (en) 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
DE10399023I2 (de) 1989-09-12 2006-11-23 Ahp Mfg B V TFN-bindende Proteine
US6204363B1 (en) 1989-10-16 2001-03-20 Amgen Inc. Stem cell factor
US5149792A (en) 1989-12-19 1992-09-22 Amgen Inc. Platelet-derived growth factor B chain analogs
US5272064A (en) 1989-12-19 1993-12-21 Amgen Inc. DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
WO1991018982A1 (en) 1990-06-05 1991-12-12 Immunex Corporation Type ii interleukin-1 receptors
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
US5554512A (en) 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
US5981713A (en) 1994-10-13 1999-11-09 Applied Research Systems Ars Holding N.V. Antibodies to intereleukin-1 antagonists
KR100510234B1 (ko) 1995-06-29 2005-11-25 임뮤넥스 코포레이션 세포소멸을 유도하는 시토킨
US6613544B1 (en) 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US6096728A (en) 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
US6235883B1 (en) 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
US6337072B1 (en) 1998-04-03 2002-01-08 Hyseq, Inc. Interleukin-1 receptor antagonist and recombinant production thereof
AU1920301A (en) 1999-11-17 2001-05-30 Immunex Corporation Receptor activator of nf-kappa b
GB0304253D0 (en) * 2003-02-25 2003-03-26 Polymer Lab Ltd Apparatus
US20110121093A1 (en) * 2008-03-19 2011-05-26 Waters Technologies Corporation Apparatus And Methods For Making Analyte Particles
KR20110116011A (ko) 2008-12-10 2011-10-24 올테크 어소시에이츠, 인크. 증발형 광 산란 검출기와 같은 장치에서 사용하기에 적합한 부품
BRPI0923191A2 (pt) * 2008-12-19 2016-02-16 Momenta Pharmaceuticals Inc metodos relacionados com glicanos modificados
MX2011007545A (es) * 2009-01-22 2011-10-28 Momenta Pharmaceuticals Inc N-glicanos que contienen galactosa-alfa-1,3-galactosa en productos de glicoproteina derivados de celulas de ovario de hamster chino (cho).
JP5615537B2 (ja) * 2009-12-02 2014-10-29 東光薬品工業株式会社 抗病原性微生物剤、並びに、マスク及びフィルター
EP2673065B1 (en) 2011-02-10 2015-12-09 Academisch Ziekenhuis Leiden Acting Under The Name Leiden University Medical Center Method for the purification of a glycan and/or a glycoconjugate by chromatography using a stationary phase comprising cotton
JP2015513674A (ja) * 2012-02-27 2015-05-14 バイオジェン アイデック エムエー インコーポレイティドＢｉｏｇｅｎ Ｉｄｅｃ Ｉｎｃ． シアル酸定量のためのハイスループット方法
WO2013155324A1 (en) * 2012-04-11 2013-10-17 Biogen Idec Ma Inc. Methods of detecting glycosaminoglycans
US8834796B2 (en) * 2012-04-13 2014-09-16 Waters Technologies Corporation Chromatographic optical detection system
WO2014072503A1 (en) * 2012-11-09 2014-05-15 Dsm Ip Assets B.V. A method for analyzing a solution, a device for analyzing a solution as well as a system for analyzing a solution
US9169331B2 (en) * 2012-12-21 2015-10-27 Dionex Corporation Separation of glycans by mixed-mode liquid chromatography

Also Published As

Publication number Publication date
EP3540071B1 (en) 2023-09-06
CA2968372A1 (en) 2016-05-26
EP3221465B1 (en) 2019-03-13
JP2018502287A (ja) 2018-01-25
MX2017006463A (es) 2018-04-20
JP7055837B2 (ja) 2022-04-18
EP3540071A1 (en) 2019-09-18
AU2015349809B2 (en) 2022-02-10
EP3221465A1 (en) 2017-09-27
AU2015349809A1 (en) 2017-05-25
ES2962593T3 (es) 2024-03-20
ES2727380T3 (es) 2019-10-15
US20180321252A1 (en) 2018-11-08
WO2016081770A1 (en) 2016-05-26
US11275090B2 (en) 2022-03-15
JP2020187128A (ja) 2020-11-19
HK1244037B (en) 2019-11-15

Similar Documents

Publication Publication Date Title
MX383470B (es) Cuantificación de porción de glicano en glicoproteínas recombinantes.
CY1123247T1 (el) Διεργασια για το χειρισμο του επιπεδου της περιεκτικοτητας σε γλυκανη μιας γλυκοπρωτεϊνης
EP3850110A4 (en) MODIFIED ARCHAEAL POLYMERASES OF THE B FAMILY
EP3316321A4 (en) WHITE LIGHT SOURCE SYSTEM
ECSP18000844A (es) Anticuerpos de unión a tau
EP3285635A4 (en) SYSTEMS AND METHOD FOR DETERMINING A DISTANCE OF ONE OBJECT
SMT201600392B (it) Anticorpi bispecifici diretti contro cd3epsilon e bcma
EP4024454C0 (en) WHITE LIGHT SOURCE SYSTEM
ECSP18000887A (es) Anticuerpos de unión a tau
DK3313882T3 (da) Anti-VISTA antistoffer og fragmenter
EP3402384A4 (en) SYSTEMS AND METHOD FOR DETERMINING A DISTANCE FROM ONE OBJECT
EP3191599C0 (en) DETECTION OF MISFOLDED PROTEINS
DK3254016T3 (da) Lys
PL3035245T3 (pl) Sposób rozpoznawania typu pojazdu i system szybkiej kontroli pojazdu przy użyciu wspomnianego sposobu
MA42707A (fr) Systèmes et procédés de détection multiplexée de biomarqueurs
PL3289832T3 (pl) Ulepszanie źródła światła
EP3281000A4 (en) METHOD AND SYSTEM FOR FLUORESCENT DETECTION
EP3397946A4 (en) OPTICAL DETECTION SYSTEM FOR PARTICLES
EP3316322C0 (en) WHITE LIGHT SOURCE SYSTEM
EP3333630A4 (en) LIGHT SOURCE SYSTEM AND PROJECTION SYSTEM
EP3350643A4 (en) PTYCHOGRAPHIESYSTEM
EP3318873A4 (en) TEST SYSTEM
EP3532957A4 (en) Flash transaction file system
EP3338310A4 (en) Light source
EP3367838A4 (en) FOOTWEAR CLOSURE